Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
AstraZeneca
AstraZeneca
Bristol-Myers Squibb
Australasian Gastro-Intestinal Trials Group
UNICANCER
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Icahn School of Medicine at Mount Sinai
Sumitomo Pharma America, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Kansas Medical Center
University of Chicago
University of Utah
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb